Prospective Study on COVID -19 Reinfection on Vaccinated and Non-vaccinated Outpatients

the aim of the study is to compare the severity of symptoms in case of reinfection with COVID-19. the study will compare between two groups; vaccinated and non vaccinated. the side effects from vaccination and symptoms of infection and reinfection will be reprted.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COVID-19 Pandemic COVID-19 Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Deraya university

Minya, 05673, Egypt

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

clinically diagnosed with COVID infection
take any type of vaccines

Exclusion criteria

no accept sharing
not vaccinated with COVID vaccine

Treatment and study plan

COVID-19 vaccin

Biological

injection

Primary outcomes

percent of reinfection with COVID-19 in vaccinated and non vaccinated

Time frame: one year

Secondary outcomes

scoring of symptoms in case of reinfection in vaccinated and non vaccinated

Time frame: one year

Sponsors and collaborators

Lead sponsor

Soad Ali

Other

Registry information

Important dates

Study start: 2021
Primary completion: 2022
Study completion: 2022
First posted: Aug 9, 2024
Registry last updated: Aug 9, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed